Related Experiment Video
Updated: Jun 15, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Secondary prevention after coronary artery bypass grafting--what do we know?
1Division of Cardiology, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden. johan.herlitz@hjl.gu.se
Insights
Secondary prevention after coronary artery bypass grafting (CABG) needs more research. While smoking cessation and LDL cholesterol reduction are recommended, optimal antiplatelet and antithrombotic strategies require further study for improved patient outcomes.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Preventive Medicine
Background:
- Secondary prevention guidelines are largely based on myocardial infarction and angina patients, not specifically coronary artery bypass grafting (CABG) patients.
- Existing knowledge for CABG patients is limited, creating a gap in optimal post-operative care strategies.
Purpose of the Study:
- To highlight the current gaps in knowledge regarding secondary prevention following coronary artery bypass grafting (CABG).
- To identify areas where further research is needed to optimize treatment regimens for CABG survivors.
Main Methods:
- Review of existing literature and guidelines for secondary prevention in cardiovascular disease.
- Analysis of current recommendations and identification of uncertainties specific to the CABG population.
Main Results:
- Smoking cessation and low-density lipoprotein (LDL) cholesterol reduction are established recommendations.
- Optimal antiplatelet and antithrombotic treatment strategies post-CABG remain uncertain.
- Behavior modification shows potential benefits but requires more investigation.
Conclusions:
- There is a significant need for more research into secondary prevention specifically for coronary artery bypass grafting (CABG) patients.
- Further studies are required to define optimal antiplatelet and antithrombotic therapies.
- Improving secondary prevention strategies can enhance long-term outcomes for CABG patients.
Abstract:
There is insufficient knowledge about secondary prevention after coronary artery bypass grafting (CABG). Most of it is gathered from patients suffering from myocardial infarction and angina pectoris, only a minority of whom have undergone CABG. Whereas it seems clear that these patients should give up smoking and reduce low-density lipoprotein (LDL) cholesterol, there is uncertainty about the optimal antiplatelet regimen and antithrombotic treatment. There are some data indicating the benefit of behaviour modification. There is room for improvement and more knowledge when it comes to secondary prevention after CABG.
More Related Videos
09:04Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
Published on: November 19, 2019
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management